Group Leader of Drug Discovery Group
Meet AJ Singhal!
AJ Singhal is the Group Leader of the Drug Discovery Group at CFD Research. After starting the bio-based program, AJ decided to reach even higher and start a spin-off entity known as PoP Therapeutics. The last five years he has worked alongside his twin brother, CEO Sameer Singhal, helping develop the company their father started in their basement 35 years ago. Moving forward, AJ will lead the bio program at CFD while holding the title of CEO of PoP Therapeutics. His goal is to get more antibiotics to the market, and hopes to do so in the years to come.